2021年4月5日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿3188万,过去10天国内接种疫苗5000万剂次

2021-04-05 MedSci整理 MedSci整理

Worldometers世界实时统计数据显示,截至北京时间2021年4月5日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过13188万例,新增518,202例,达到131,889,040

Worldometers世界实时统计数据显示,截至北京时间2021年4月5日7时01分,全球累计确诊新冠肺炎COVID-19)病例超过13188万例,新增518,202例,达到131,889,040例。累计死亡病例超286.5万例,达到2,865,447例,新增死亡为6,424例。康复为106,182,305例,重症和危重症病人达到98,827例;全球新冠确诊病例超过100万例的国家达21个,87个国家病例超10万例。美国新冠肺炎累计确诊病例全球最多,超过3141万例,达到31,419,437例,新增36,089例;累计死亡病例超过56.8万例,达到568,764例,新增死亡257例。巴西疫情昨日新增31,359例,印度新增103,793例,首次超过10万例。昨日报道:2021年4月4日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿3132万,全球疫情再度恶化,我国单日疫苗接种突破700万剂

中国新冠疫苗在欧盟获得GMP认证

4月1日,匈牙利国家药品审批监管机构向国药集团中国生物北京生物制品研究所正式颁发新冠灭活疫苗欧盟GMP证书。这是中国历史上首个在欧盟获批使用和GMP认证的疫苗产品,迈出了中国新冠疫苗成为全球公共产品新的一步。

我国已接种新冠病毒疫苗13667.7万剂次

国家卫健委4日发布,截至2021年4月3日,各地累计报告接种新冠病毒疫苗13667.7万剂次。 ​​​​过去7天里,各地新增接种新冠疫苗3006.4万剂次。国家卫健委自3月24日起施行疫苗接种日报告制度以来,全国10天已接种疫苗5095.5万剂次,日均接种达到509.55万剂次,最高单日接种718.5万剂次。全国多地已陆续公布新冠疫苗接种最新数据,其中北京、广东、山东三地累计接种均已突破1000万剂次。

国家卫健委疾控局副局长吴良有介绍,目前全国各地正按照“应接尽接、梯次推进、突出重点、保障安全”的原则,做好重点地区和重点行业人群的接种工作,集中力量在疫情发生风险高的大中型城市、口岸城市、边境地区来开展接种。“下一步将继续做好重点地区、重点人群的接种工作,积极稳妥拓展接种服务能力,优化疫苗的配送流程,提高流转和运输效率,科学安排疫苗周转数量,通过多种方式增加接种点和接种台数量,满足群众的接种需求。同时,加强部门联动,协调工业和信息化部门来加强疫苗的供应保障。”吴良有说。

德国新冠肺炎重症患者再次超过4000人

当地时间4日,德国跨学科急救医学协会(DIVI)在每日新冠感染报告中指出,自2月初以来,德国重症监护病房收治的新冠肺炎感染患者再次超过4000例。 截至当天,该国有4051名患者接受重症监护治疗,比前一天增加了133人。其中,有55%的患者需在重症监护病房中接受侵袭性呼吸器治疗。

美国单日新增确诊病例超3.5万例 变异新冠病毒肆虐美国

根据Worldometer实时统计数据,截至北京时间4月5日6时30分左右,美国累计确诊新冠肺炎病例31416291例,累计死亡病例568722例。与前一日6时30分数据相比,美国新增确诊病例35686例,新增死亡病例228例。

华盛顿大学健康指标与评估研究所(IHME)当地时间4月3日表示,变异新冠病毒B.1.1.7正在美国加速传播,在这种情况下美国各州过快的重新开放,加之传统节日假期等因素,可能使美国在4月和5月新冠肺炎确诊病例激增。

据美国交通安全管理局发布的数据,4月2日当天,美国境内有1580785人通过机场安检,预计航空旅行人数将在节日期间继续上升。综合所有情况,IHME将其对截至7月1日美国新冠肺炎死亡总人数的估算从60万增加到了60.9万。根据美国疾病控制与预防中心(CDC)最新数据,目前在美国境内发现了13052例感染了英国、南非和巴西等地发现的变异新冠病毒。

英国单日新增确诊病例2297例拟试水“新冠疫苗护照”

当地时间4月4日,英国卫生和社会保障部公布最新数据显示,过去24小时英国新增新冠肺炎确诊病例2297例,累计确诊4359388例;新增死亡病患10例,累计死亡126836例。

英国政府计划近期在多场公共活动中试水使用“新冠疫苗护照”。不过这一方案招致多种反对声音。据英国《卫报》3日报道,英国首相鲍里斯·约翰逊定于5日宣布试点疫苗护照的一系列公共活动。一些议员反对使用疫苗护照,其中不乏资深保守党议员。一些议员在研究是否强行针对该议题在议会表决。一个跨党派团体宣布反对疫苗护照方案。72名议员签署一份声明,称疫苗护照具有“分裂性和歧视性”。一名政府科学顾问则警告说,疫苗护照会让人们产生一种“虚假的安全感”。

俄罗斯单日新增确诊病例8212例 利比亚接收俄“卫星V”疫苗

据俄罗斯新冠病毒防疫官网4日公布的最新数据,俄罗斯新增例新冠肺炎确诊病8212例,累计确诊4580894例,新增新冠肺炎死亡病例357例,累计死亡100374例。

当地时间4月4日,利比亚卫生部表示,第一批新冠疫苗于4月3日运抵的黎波里,该批疫苗为俄罗斯“卫星V”疫苗。卫生部表示该批疫苗将会在分发前会储存在卫生部的仓库内,利比亚临时总理阿卜杜勒·哈米德·德贝巴表示,更多的疫苗将会陆续运抵利比亚。

巴西单日新增确诊病例超3万例 多地住院人数迎峰值

截至当地时间4月4日,巴西新冠肺炎累计确诊病例达12984956例,较前一日新增31359例;累计死亡病例331433例,较前一日新增1240例。

在确诊人数最多的圣保罗州,重症监护病床占用率已达91.4%,目前全州超过30000名新冠肺炎患者住院治疗,其中13000名重症患者在重症监护室接受治疗,病床位一位难求。截至4日,圣保罗州已有510名新冠肺炎患者已完成登记排队入院手续,但在等待床位的过程中离世。知名旅游城市里约热内卢市也迎来了住院就诊人数的峰值,当日该市公共医疗系统内病床占用率达到92%,167名患者排队等待床位。

法国疫情持续恶化

海口暂停第二针新冠疫苗接种,预计4月中下旬重启

将于4月中下旬启动新冠疫苗第二针剂接种工作,具体时间另行通知。届时各接种门诊会按照受种者达到时间间隔的先后顺序进行有序预约和接种

文莱正式启动全国新冠疫苗接种

文莱正式启动全国新冠疫苗接种 4月3日,文莱防疫一线人员在斯里巴加湾市接种中国国药集团新冠疫苗后合影留念。 文莱政府3日正式启动全国新冠疫苗接种工作,为18周岁以上的本国国民和外国居民免费提供疫苗接种服务

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 DIfh

    形式很严峻,还需努力

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 医鸣惊人

    认真学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 易水河

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 ms6000000856968793

    继续关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 嗯哼。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 Zhlzeng169

    还是不能放松警惕

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1632383, encodeId=ec03163238339, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Tue May 11 21:02:34 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954011, encodeId=f0f7954011bf, content=形式很严峻,还需努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Mon Apr 05 20:14:05 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953998, encodeId=bc2f953998ba, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Apr 05 19:21:26 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953977, encodeId=c9f09539e7d6, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Mon Apr 05 17:17:16 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953970, encodeId=ef689539e0e9, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75453347, createdName=ms6000000856968793, createdTime=Mon Apr 05 16:45:37 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953966, encodeId=66cf953966ba, content=唉, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9825477032, createdName=嗯哼。, createdTime=Mon Apr 05 16:23:14 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953942, encodeId=688e9539422e, content=哇, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=513f5312836, createdName=1488f5d7m66(暂无昵称), createdTime=Mon Apr 05 14:48:07 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953932, encodeId=ab81953932da, content=还是不能放松警惕, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d642976094, createdName=Zhlzeng169, createdTime=Mon Apr 05 13:32:03 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029356, encodeId=5a351029356be, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Apr 05 11:02:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953896, encodeId=3e279538968d, content=希望慢性病患者的疫苗早日出现, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/11d03c3c409f49d19d57d8a5c9eab790/e2dadfd43c3e47b0aca7f8630029cad4.jpg, createdBy=3aed1876781, createdName=ms4456776505761571, createdTime=Mon Apr 05 10:01:55 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 ms4456776505761571

    希望慢性病患者的疫苗早日出现

    0

相关资讯

2021年4月2日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿3013万,辉瑞疫苗半年期有效率仍达91%

Worldometers世界实时统计数据显示,截至北京时间2021年4月2日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过13013万例,新增670,474例,达到130,133,494

2021年4月4日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿3132万,全球疫情再度恶化,我国单日疫苗接种突破700万剂

Worldometers世界实时统计数据显示,截至北京时间2021年4月4日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过13132万例,新增518,095例,达到131,322,887

辉瑞/BioNTech新冠疫苗保护期6个月有效率仍达91.3%

辉瑞/BioNTech声明称,其联合开发的新冠疫苗在预防有症状的新冠感染方面非常有效,在接种第二次之后保护期长达六个月。

世卫组织建议仅在临床试验中使用伊维菌素

世卫组织发布声明,声明指出,使用伊维菌素治疗新冠肺炎患者方面尚无定论。

2021年4月3日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿3077万,国内部分地区疫苗供应紧张,新冠病毒持久症状高达14%

Worldometers世界实时统计数据显示,截至北京时间2021年4月3日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过13077万例,新增614,426例,达到130,779,425

BMJ:英国新冠肺炎VOC-202012/01变异株导致的患者死亡风险增加64%

2020年10月初,研究人员从英格兰东南部的新冠肺炎患者中,首次分离了变异株B.1.1.7(VOC 202012/1)。